- Home
- SCNI vs UOKA Comparison
SCNI vs UOKA Comparison
Compare SCNI & UOKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNI
- UOKA
- Stock Information
- Founded
- SCNI 2003
- UOKA 2002
- Country
- SCNI Israel
- UOKA United Kingdom
- Employees
- SCNI N/A
- UOKA N/A
- Industry
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- UOKA
- Sector
- SCNI Health Care
- UOKA
- Exchange
- SCNI Nasdaq
- UOKA NYSE
- Market Cap
- SCNI 2.8M
- UOKA 2.6M
- IPO Year
- SCNI N/A
- UOKA N/A
- Fundamental
- Price
- SCNI $3.52
- UOKA $0.17
- Analyst Decision
- SCNI
- UOKA
- Analyst Count
- SCNI 0
- UOKA 0
- Target Price
- SCNI N/A
- UOKA N/A
- AVG Volume (30 Days)
- SCNI 20.5K
- UOKA 27.2M
- Earning Date
- SCNI 11-22-2024
- UOKA 03-04-2025
- Dividend Yield
- SCNI N/A
- UOKA N/A
- EPS Growth
- SCNI N/A
- UOKA N/A
- EPS
- SCNI 8.20
- UOKA N/A
- Revenue
- SCNI $452,000.00
- UOKA $114,849.00
- Revenue This Year
- SCNI N/A
- UOKA N/A
- Revenue Next Year
- SCNI N/A
- UOKA N/A
- P/E Ratio
- SCNI $0.43
- UOKA N/A
- Revenue Growth
- SCNI N/A
- UOKA 289.97
- 52 Week Low
- SCNI $2.23
- UOKA $0.13
- 52 Week High
- SCNI $8.92
- UOKA $1.80
- Technical
- Relative Strength Index (RSI)
- SCNI 52.91
- UOKA N/A
- Support Level
- SCNI $3.30
- UOKA N/A
- Resistance Level
- SCNI $3.60
- UOKA N/A
- Average True Range (ATR)
- SCNI 0.25
- UOKA 0.00
- MACD
- SCNI -0.01
- UOKA 0.00
- Stochastic Oscillator
- SCNI 44.05
- UOKA 0.00
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.
About UOKA MDJM LTD
MDJM Ltd is a real estate service company. The company provides real estate agency services to real estate developer clients, as well as real estate consulting services and independent training services on an as-needed basis. It offers consulting, marketing planning, advertising services, and sales strategies to real estate clients. The company income is derived from commission-based services and minimal consulting and other services. The company has two operating segments; the real estate agent services segment and the hospitality business segment. It derives a majority of its revenue from the People's Republic of China.